Renal cell carcinoma (RCC) had historically been regarded as a disease that was refractory to therapy once surgical options had been exhausted.
Edwin M. Posadas, MD, FACP
Advertisement
Articles by Edwin M. Posadas, MD, FACP
Advertisement
Latest Updated Articles
- Systemic Therapy in Renal Cell Carcinoma: Advancing Paradigms
Published: March 15th 2012 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Response Rates Show Promise in Phase 1 Trial Involving ASCT in Metastatic PDAC
2
Case 2: Patient With High-Risk RRMM Relapsing After BCMA CAR T-Cell Therapy
3
JSKN003 Receives FDA Fast Track Designation in Advanced PROC
4
Belzutifan Plus Lenvatinib Improves PFS/ORR in Advanced Pretreated RCC
5
